Valuation: Southern Acids (M)

Market Cap 41Cr 10Cr 8.78Cr 8.18Cr 7.53Cr 14Cr 964.81Cr 14Cr 96Cr 38Cr 483.25Cr 38Cr 37Cr 1.6TCr P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value -1.16Cr -28.25L -24.44L -22.78L -20.97L -39.51L -27Cr -40.04L -2.68Cr -1.05Cr -13Cr -1.06Cr -1.04Cr -45Cr EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.64%
Yield 2025
1.64%
Yield 2026 1.65%
1 day-1.30%
Current month-1.30%
3 months-0.66%
6 months-9.28%
Current year-4.72%
1 week 3.03
Extreme 3.03
3.08
1 month 3.02
Extreme 3.02
3.12
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 15/07/2015
Director of Finance/CFO 58 01/10/2013
Chief Tech/Sci/R&D Officer 38 16/07/2014
Director TitleAgeSince
Director/Board Member 66 10/08/2005
Director/Board Member 59 20/03/2012
Chairman 79 15/07/2015
Change 5-day change 1-year change 3-year change Capi.($)
-1.30%0.00%-10.88%-9.82% 10Cr
-0.14%-0.10%+40.40%+428.38% 600.12Cr
-0.41%-1.08%+24.79%+98.37% 172.96Cr
-1.89%+16.45%+32.97%+87.43% 90Cr
-2.21%+2.31%+44.57%+107.81% 58Cr
+0.77%+6.92%+28.05%+7.91% 58Cr
+0.38%+6.26%-17.94%-31.06% 50Cr
+2.62%+12.48%+46.31%-0.60% 39Cr
-0.80%-5.01%-0.05%+0.65% 37Cr
-0.88%-2.92%-0.44%+23.90% 29Cr
Average -0.39%+1.80%+18.78%+71.30% 114.46Cr
Weighted average by Cap. -0.31%-1.90%+31.90%+251.42%

Financials

2025 2026
Net sales 110.6Cr 27Cr 23Cr 22Cr 20Cr 38Cr 2.57TCr 38Cr 256.36Cr 100.5Cr 1.29TCr 101.56Cr 99Cr 4.26TCr 93Cr 23Cr 20Cr 18Cr 17Cr 32Cr 2.17TCr 32Cr 216.39Cr 85Cr 1.09TCr 86Cr 84Cr 3.6TCr
Net income 3.67Cr 89.74L 77.63L 72.37L 66.61L 1.25Cr 85Cr 1.27Cr 8.51Cr 3.34Cr 43Cr 3.37Cr 3.3Cr 141.5Cr 3.74Cr 91.39L 79.06L 73.7L 67.83L 1.28Cr 87Cr 1.3Cr 8.66Cr 3.4Cr 44Cr 3.43Cr 3.36Cr 144.1Cr
Net Debt -37Cr -8.97Cr -7.76Cr -7.23Cr -6.66Cr -13Cr -853.12Cr -13Cr -85Cr -33Cr -427.3Cr -34Cr -33Cr -1.41TCr -43Cr -10Cr -9.02Cr -8.41Cr -7.74Cr -15Cr -991.68Cr -15Cr -99Cr -39Cr -496.71Cr -39Cr -38Cr -1.64TCr
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
05/26/05 MYR 3.030 -1.30% 10,300
31/26/31 MYR 3.070 +1.66% 100
29/26/29 MYR 3.020 -0.33% 3,800
28/26/28 MYR 3.030 -1.30% 6,100
  1. Stock Market
  2. Stocks
  3. 5134 Stock